Literature DB >> 34021841

The target on B cells in Systemic Sclerosis: a "midsummer dream" to extinguish inflammation and prevent early disease progression to fibrosis.

Giacomo De Luca1,2, Alessandro Tomelleri1,2, Lorenzo Dagna1,2, Marco Matucci-Cerinic3,4.   

Abstract

Entities:  

Year:  2021        PMID： 34021841     DOI： 10.1007/s10067-021-05733-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  26 in total

1.  Interleukin-6 is a growth factor for nonmalignant human plasmablasts.

Authors:  G Jego; R Bataille; C Pellat-Deceunynck
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

2.  Polyclonal B lymphocyte activation in progressive systemic sclerosis.

Authors:  G Famularo; R Giacomelli; E Alesse; M G Cifone; S Morrone; M Boirivant; C Danese; M A Perego; A Santoni; G Tonietti
Journal:  J Clin Lab Immunol       Date:  1989-06

3.  Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.

Authors:  Silvia Bosello; Umberto Basile; Enrico De Lorenzis; Francesca Gulli; Giovanni Canestrari; Cecilia Napodano; Federico Parisi; Krizia Pocino; Clara Di Mario; Barbara Tolusso; Gianfranco Ferraccioli; Elisa Gremese
Journal:  J Clin Pathol       Date:  2018-01-31       Impact factor: 3.411

Review 4.  B cells in systemic sclerosis: a possible target for therapy.

Authors:  Silvia Bosello; Giacomo De Luca; Barbara Tolusso; Gina Lama; Cristiana Angelucci; Gigliola Sica; Gianfranco Ferraccioli
Journal:  Autoimmun Rev       Date:  2011-04-22       Impact factor: 9.754

5.  Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.

Authors:  C Lunardi; C Bason; R Navone; E Millo; G Damonte; R Corrocher; A Puccetti
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

6.  B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis.

Authors:  Robert Lafyatis; Eugene Kissin; Michael York; Giuseppina Farina; Kerry Viger; Marvin J Fritzler; Peter A Merkel; Robert W Simms
Journal:  Arthritis Rheum       Date:  2009-02

7.  B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.

Authors:  Noriko Asano; Manabu Fujimoto; Norihito Yazawa; Senji Shirasawa; Minoru Hasegawa; Hitoshi Okochi; Kunihiko Tamaki; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

8.  Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.

Authors:  Shinichi Sato; Manabu Fujimoto; Minoru Hasegawa; Kazukiko Takehara
Journal:  Arthritis Rheum       Date:  2004-06

9.  CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

Authors:  Ayumi Yoshizaki; Yohei Iwata; Kazuhiro Komura; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

10.  Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression.

Authors:  Silvia Bosello; Cristiana Angelucci; Gina Lama; Stefano Alivernini; Gabriella Proietti; Barbara Tolusso; Gigliola Sica; Elisa Gremese; Gianfranco Ferraccioli
Journal:  Arthritis Res Ther       Date:  2018-04-18       Impact factor: 5.156
View more
  1 in total

Review 1.  New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics.

Authors:  Satoshi Ebata; Asako Yoshizaki-Ogawa; Shinichi Sato; Ayumi Yoshizaki
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.